Background/Aims: With the prevalence of asthma being greater in women, detrimental effects of female sex steroids have been explored, but potential protective effects of androgens are not established. Airway smooth muscle (ASM) is a key cell type in contractility and remodelling of asthma. There are no data on expression and functionality of androgen receptor (AR) in human ASM cells. Methods: We used primary human ASM cells from non-asthmatics vs. asthmatics to determine AR expression at baseline and with inflammation measured using Western blotting/qRT-PCR, and the role of AR in regulating intracellular Ca 2+ ([Ca 2+ ] i ) measured using Fluo-3 loaded real time [Ca 2+ ] i imaging. Results: We found that compared to females, baseline AR is greater in male ASM and increases with inflammation/asthma. Androgens, via AR, blunted TNFα or IL-13-induced enhancement of ASM [Ca 2+ ] i in both males and females, with retained efficacy in asthmatics. AR effects involve reduced Ca 2+ influx via L-type channels and store-operated Ca 2+ entry, the latter by downregulating STIM1 and Orai1 and increasing TMEM66. Conclusion: Our data show AR expression is increased in female ASM with asthma, but has retained functionality that could be used to reduce [Ca 2+ ] i towards alleviating airway hyperresponsiveness. Kalidhindi et al.: Androgen Receptor in Airway Smooth Muscle latter a result of increased cell proliferation and fibrosis [1, 2] . Asthma in adults shows a sex difference where for example, in 2014, ~60% of the 3, 651 deaths attributed to asthma occurred in women (American Lung Association) [3] . Amongst the general adult population, asthma prevalence is higher in women than men with distinctive changes in the prevalence and severity of asthma with age [4, 5] . Asthma increases steadily in both sexes from birth onwards to the early teenage years, but is significantly higher in males. From teenage years through midlife, prevalence decreases dramatically in males, but increases in females. With subsequent aging, prevalence increases in males and decreases in females, converging in late adulthood [4, 6] . These clinical data highlight the potential modulatory role of sex hormones on the prevalence and severity of asthma.
Introduction
Bronchial asthma is a leading cause of morbidity across the age spectrum, and involves increased airway inflammation, epithelial mucus secretion, airway hyperreactivity involving enhanced airway smooth muscle (ASM) contractility, and chronic airway remodelling, the Cell Treatments Human ASM cells in T-75 flasks were trypsinized and mixed in 10% FBS (Charcoal Stripped) Growth medium (DMEM/F12 with 1% AbAm), counted and seeded ~10, 000 cells/well into 8-well chamber slides. Cells were incubated overnight followed by serum deprivation (DMEM/F12 without FBS) for 24 h. ASM cells were treated with AR agonists Testosterone (TES, 10 nM) or 5-alpha-DiHydro Testosterone (5αDHT/ DHT, 10 nM) with or without flutamide (AR antagonist) in serum free media. After 2 h of pre-incubation with respective treatment groups, cells were then exposed to TNFα (20 ngml -1 ) or IL-13 (50 ngml -1 ) for 24h. Serum free media alone served as vehicle. Similarly, ASM cells were grown on 100 mm petri plates and treated as above to collect lysates for protein or mRNA for western and qRT-PCR analysis respectively.
qRT-PCR Analysis
Cells were washed with RNA-grade DPBS, trypsinized and centrifuged. Total RNA was extracted using Quick-RNA™ MiniPrep kit (Zymo Research, Irvine, CA) following manufacturer's protocol. cDNA was synthesized using OneScript cDNA Synthesis Kit using ~500-600ng of quantified RNA (Take3™ Micro volume plate, Synergy HTX, Biotek, USA) for each sample (Applied Biological Materials Inc , Richmond, BC, Canada). LightCycler 480 SYBR Green I Master PCR kit (Cat# 0470751601) protocol was followed using QuantStudio 3 RT-PCR system as per the manufacturer's instructions. The following primers were used for RT-PCR analysis: AR (forward 5'-GCC TTG CTC TCT AGC CTC AA-3', reverse 5'-GGT CGT CCA CGT GTA AGT TG-3') and s16 (forward 5′-CAA TGG TCT CAT CAA GGT GAA CGG-3′, reverse 5′-CTG GAT AGC ATA AAT CTG GGC-3′). The fold changes in mRNA expression were calculated by normalization of cycle threshold [C(t)] value of target genes to reference gene s16 using the ΔΔCt method [14, 15, 36] .
Western analysis
Previously described techniques were used [14, 37] . Briefly, cells were washed, sonicated in lysis buffer (Cell Signaling Technologies, Beverly, MA, USA) containing protease and phosphatase inhibitors, and resultant supernatants were assayed for total protein content using the DC Protein Assay kit (BioRad, Hercules, CA, USA). 30 µg equivalent protein from each lysate were loaded on 4-15% SDS-page and transferred onto 0.22 µm PVDF membranes. Non-specific binding was blocked using 5.0% bovine serum albumin (BSA) and the membranes were probed overnight at 4°C with specific primary antibodies of interest (Androgen receptor, STIM1, Orai-1 and TMEM66 with β-actin as a loading control). Blots were then incubated with LiCOR nearred conjugated or HRP conjugated secondary antibodies. Membranes were scanned using LiCOR Odyssey CLX or developed on radiography films and densitometry analysis was performed using Image Studio version 5.2 software or Image J (NIH).
Real-time Intracellular Calcium [Ca 2+ ] i Imaging
After 24 hours of incubation with the respective treatments, drug solutions (media) were aspirated and human ASM cells were washed with freshly prepared HBSS (1X) buffer solution. Further, they were incubated with 4 µM Fluo-3 dye (prepared in HBSS solution) for 1 h at room temperature. Following an hour, the dye was aspirated, and cells were washed twice with HBSS buffer solution. The ASM cells were imaged at a 20X oil-magnification on GFP fluorescence (excitation 475-495 nm, and emission 520-560 nm) in the Biotek Lionheart FX automated live cell imaging system [16, 34, [38] [39] [40] .
AR siRNA studies
Human ASM cells were cultured in 8-well plates or 100 mm plates to approximately 50% confluence. Transfection was achieved using 20 nM AR siRNA (Cat# SO-2685308G) and Lipofectamine 3000 transfection reagent (Invitrogen) in DMEM/F-12 and 5% FBS lacking antibiotics. Fresh growth medium was added after 6 h and cells were analyzed after 48 h. Negative Control siRNA (Cat# AM4611) was procured from Ambion. Efficacy and specificity of siRNA knockdown was verified using Western analysis. The effect of AR siRNA on [Ca 2+ ] i in the presence and absence of TNFα, IL-13 and Testosterone were analyzed as mentioned above.
Store Operated Calcium Entry (SOCE)
For SOCE imaging, cells were washed with HBSS (with 2.5 mM Ca 2+ ) and then loaded with 4 µM Fluo-3 AM dye for 1h at room temperature. The cells were then washed three times with 1X HBSS ("0" calcium) and proceeded with imaging in an Olympus FV-300 imaging station with shutter control system and CCD camera using a FITC filter. Solutions were added to the wells using a peristaltic pump system with a fixed flow rate. The overflowing solution was aspirated using a vacuum pump attached to the system. Initially HBSS without calcium was passed and for 2 min, followed by HBSS (without calcium) with 10 µM KCL for 4 min and HBSS (without calcium) with 10 µM KCL and 1 µM Nifedipine for 4 min. Images were captured every 10 seconds using Cell Sens software. The cells were then subjected to HBSS ("0" calcium) with 10 µM KCL, 1 µM Nifedipine and 10 µM CPA for 4 minutes, followed by introducing Ca 2+ in the same solution for 2 minutes. During this phase, images were captured every 1 second. Region of interest's (ROI) were selected randomly from 5-10 cells and change in fluorescence intensity was recorded using Cell Sense software (Olympus Inc., USA) [38, 40] .
Statistical analysis
Experiments were performed in human ASM cells from 3-5 patients (non-asthmatic males, nonasthmatic females, asthmatic males and asthmatic females). "n" values represent patient numbers for individual experiments. All the experiments were repeated at least two times for each patient sample. Data expressed as mean ± SEM. Statistical analysis was performed using individual one-way ANOVA or two-way ANOVA with Bonferroni post-hoc test where applicable. Statistical significance was tested at minimum of p<0.05 level.
Results

AR expression in human ASM cells
Baseline mRNA expression of AR was significantly higher (p<0.05) in male non-asthmatic human ASM cells compared to female non-asthmatic ASM cells. Western analysis of ASM cell lysates also indicated significantly higher (p<0.01) AR expression in male non-asthmatics compared to female non-asthmatics. In asthmatic human ASM cells, AR mRNA and protein expression were significantly greater in both males (p<0.05 for mRNA and p<0.01 for protein) and females (p<0.05 for mRNA and p<0.01 for protein) compared to non-asthmatic human ASM cells ( Fig. 1A and 1B) . Notably, AR expression was markedly greater in female asthmatic ASM cells compared to non-asthmatics and the increase was comparable to that in males ( Fig. 1A, B ).
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry 
Effect of inflammation on AR expression in human ASM cells
In non-asthmatic human ASM cells of both males (p<0.001) and females (p<0.01), AR mRNA expression was significantly increased in the presence of TNFα (20 ngml -1 ) compared to vehicle, while no significant increase was observed in cells exposed to IL-13 (50 ngml -1 ). In addition, AR mRNA expression was significantly increased (p<0.001) in asthmatic females in the presence of TNFα, while no significant changes were observed in male asthmatics exposed to TNFα ( Fig. 2A, B ). IL-13 exposed asthmatic ASM cells did not show any significant Androgen receptor (AR) expression in nonasthmatic (NA) and asthmatic human ASM cells (males and females) using qRT-PCR and Western analysis. A) mRNA expression of AR using qRT-PCR in non-asthmatic and asthmatic human ASM cells of both genders. S16 was used as internal control for normalization. B) Protein expression of AR using Western analysis in non-asthmatic and asthmatic human ASM cells of both genders. β-actin was used as loading control for normalization. AR-expression is physiologically low in females compared to males and is increased during asthma in both males and females. # p<0.05; ## p<0.01 vs.
non-asthmatic female or male, *p<0.05, **p<0.01 vs. non-asthmatic females. Data expressed as mean ± SEM. n=5 patients each. changes in AR mRNA expression. TNFα-induced increase in AR mRNA expression was more pronounced in female asthmatic human ASM (p<0.001) compared to males; whereas, in nonasthmatic human ASM cells AR mRNA expression was more in males (p<0.001) compared to females (p<0.01, Fig. 2A and 2B ). Western analysis revealed a significant increase in AR expression in non-asthmatic males and females (p<0.001) exposed to TNFα. Interestingly, IL-13 exposed cells also showed a significant increase in AR protein in male non-asthmatics (p<0.001) and female non-asthmatics (p<0.01) compared to vehicle. However, in asthmatic ASM cells, only females showed significant increase in AR expression in the presence of TNFα (p<0.001) or IL-13 (p<0.05) compared to vehicle ( Fig. 2C and 2D ).
Effect of AR activation on [Ca 2+ ] i regulation in human ASM cells
Imaging studies using Fluo-3 loaded human ASM cells showed a significant enhancement of histamine-elicited [Ca 2+ ] i response following exposure to TNFα compared to vehicle in both non-asthmatics (p<0.001 for males and females) and asthmatics (p<0.001 for males and females). TNFα enhancement of [Ca 2+ ] i tended higher in asthmatics compared to nonasthmatics. 24h exposure of TES (10 nM) did not show any significant effects on [Ca 2+ ] i responses to histamine in either non-asthmatic or asthmatic ASM cells. However, both nonasthmatic and asthmatic ASM cells treated with TES followed by TNFα exposure showed a significant decrease (p<0.001 for males and p<0.01 for females in non-asthmatics and p<0.01 for males and p<0.001 for females in asthmatics) compared to TNFα alone. Here, the effects of TES were abrogated by flutamide ( Fig. 3A and 3B) , highlighting the role of AR activation. In addition, cells treated with DHT (10 nM) followed by TNFα exposure showed significant decrease in [Ca 2+ ] i response in both males and females for non-asthmatics (p<0.001 in males and p<0.01 in females) and asthmatics (p<0.001 in males and females) compared to TNFα alone ( Fig. 3C and 3D) . Here, the effect of DHT on reducing [Ca 2+ ] i response induced by TNFα was more prominent in asthmatics compared to non-asthmatics. DHT effect was inhibited in the presence of flutamide. Human ASM cells treated with DHT alone did not show any notable changes in [Ca 2+ ] i compared to vehicle. Exposure to IL-13 resulted in a significant increase (p<0.001 in males and females) in [Ca 2+ ] i responses to histamine for both non-asthmatics and asthmatic human ASM cells. Treatment with TES blunted the effects of IL-13 in non-asthmatic and asthmatic ASM (p<0.001 both male and female, Fig. 4A and 4B ). In the presence of IL-13, DHT treated ASM cells showed significant reduction in [Ca 2+ ] i response (p<0.001, Fig. 4C and 4D ) compared to IL-13 alone. The inhibitory effects of TES and DHT on [Ca 2+ ] i in IL-13 exposed cells was not observed in the presence of flutamide.
Mechanisms of AR-mediated effects on [Ca 2+ ] i regulation
Removal of extracellular Ca 2+ still resulted in histamine-induced [Ca 2+ ] i responses that were enhanced by TNFα in both non-asthmatic (p<0.001) and asthmatic (p<0.001) ASM cells. TNFα induced increase in [Ca 2+ ] i was significantly downregulated by TES in non-asthmatic (p<0.001) and asthmatic (p<0.001) ASM cells. Similarly, even in zero extracellular Ca 2+ , IL-13 enhanced [Ca 2+ ] i responses to histamine in non-asthmatic (p<0.001) and asthmatic (p<0.001) ASM cells: effects significantly inhibited by TES in non-asthmatic (p<0.05 for males and p<0.01 for females) and asthmatic (p<0.05 for males and females) cells. TES effects were not observed in the presence of flutamide ( Fig. 5A and 5B) .
To confirm the role of ARs, we used siRNA to knockdown AR expression in ASM cells. siRNA knockdown efficiency was confirmed using Western analysis (~70% reduction; Fig.  6A, B) . AR siRNA transfected cells were exposed to TES (10 nM) for 2h and further treated with TNFα or IL-13 for 24h followed by real-time [Ca 2+ ] i imaging. AR siRNA transfected ASM cells continued to show a significant increase in [Ca 2+ ] i response to histamine following exposure to TNFα (p<0.001) and IL-13 (p<0.05) compared to negative siRNA; however, TES did not have any significant effects following with AR siRNA (Fig. 6B) .
Non-asthmatic ASM cells from males exposed to nifedipine (15 min) showed significant (p<0.05) decrease in [Ca 2+ ] i responses to histamine compared to vehicle (no nifedipine). Nifedipine did not eliminate TNFα enhancement of [Ca 2+ ] i , which was significantly reduced (p<0.01) in cells treated with TES. Similar findings were observed in the case of IL-13 exposed human ASM cells, where a significant increase (p<0.05) in [Ca 2+ ] i response was observed, which was significantly reversed (p<0.01) in TES treated cells (Fig. 6C ). TES treated cells in the presence of Nifedipine did not show any significant changes in [Ca 2+ ] i response to histamine compared to Nifedipine alone treated cells indicating the effect is partly through LTCC. Both non-asthmatic and asthmatic ASM cells demonstrated robust SOCC (as also previously shown [35, [38] [39] [40] . Non-asthmatic cells from males exposed to TNFα showed significant increase (p<0.001) in SOCE compared to vehicle. While TES did not influence the amplitude of SOCE per se, TES significantly reduced SOCE in the presence of TNFα (p<0.001). IL-13 exposed cells showed a significant increase (p<0.01) in SOCE compared to vehicle, which was significantly decreased (p<0.05) by TES ( Fig. 7A and 7B ). In addition, Western analysis showed significant increase in the expression of STIM1 (p<0.01, Fig. 7C ) and Orai1 (p<0.001, Fig. 7D ) with exposure to TNFα, which was significantly downregulated (p<0.01 for STIM1 and p<0.001 for Orai1) by pre-treatment with TES. Furthermore, TNFα exposed human ASM cells showed significant decrease in the expression of TMEM66 (p<0.001, Fig.  7E ), but TMEM66 was significantly increased (p<0.01) by pre-treatment with TES. IL-13 exposed cells did not show any significant changes in the expression of STIM1 and Orai1, but TMEM66 was significantly decreased (p<0.01) compared to vehicle: an effect blunted by TES (p<0.05). 
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Discussion
Asthma is increasing in prevalence, with substantial morbidity [5, 12, 41, 42] . The etiology of asthma involves inflammation, remodeling and AHR with an important role for ASM [5, 9, 10, 12, [43] [44] [45] [46] [47] . Evidence from clinical studies suggest sex differences in the prevalence of asthma, and a potential role of sex steroids in the pathophysiology [4] [5] [6] [48] [49] [50] [51] [52] . However, the protective vs. detrimental roles of sex steroids is less clear. Here, much of the focus has been on female sex steroids, including effects on ASM [5, 14-16, 18, 37, 53-56] , but the relative importance of male sex steroids has been less examined. In this study, we explored AR-mediated effects in the context of [Ca 2+ ] i regulation and its modulation by disease (asthma) and inflammatory cytokines, finding that TES reduces ASM [Ca 2+ ] i responses by inhibiting Ca 2+ influx and expression of relevant proteins, and is effective even in the presence of inflammation.
In animal models, significant differences between males and females with regards to fetal lung development have been reported such as delayed maturation and less surfactant in males: differences that extend to adulthood in the context of disease where for example, greater allergic airway responses are observed in female mice as well as in castrated male mice, as well as greater AHR with cholinergic stimulation in male mice [15, 17, 20, 21, 30, 31, 50] . While these data are consistent with epidemiological data suggesting women are more susceptible to asthma compared to men, they also are in contrast to a number of studies showing "protective" effects of female sex steroids in the context of ASM [Ca 2+ ] i and contractility [16] , remodeling [14, 57] and AHR [15] . Regardless, these and other data also suggest a protective role of the male sex hormone testosterone [50] [51] [52] 58] . Our data are consistent in this regard, and explore potential mechanisms of TES action.
Testosterone elicits its action through AR both genomically and non-genomically [28, 59, 60] . Several studies have reported non-genomic efefcts of TES on ASM but have relied on animal models or cells derived from non-human species [17, 19, 26, 32] . There is no information on the expression profile of AR in human ASM, especially during inflammation, or on effects of long-term activation of AR on ASM in the context of [Ca 2+ ] i homeostasis. Here, it is important to recognize that AR expression is not limited to airways of females, raising the question of whether or not AR functionality exists in both sexes and if they are quantitatively or qualitatively different. In this study, we explored sex-specific differential expression of AR in both non-asthmatic and asthmatic primary human ASM cells in the presence/absence of pro-inflammatory cytokines (TNFα and IL-13). Our studies indicate a baseline difference in the expression of AR in ASM of females (low) vs. males (high) which in many ways is to be expected, given the usual low level of androgen ligand in females and the known regulation of AR expression by receptor stimulation [28, 61] , thus resulting in reduced receptor levels in the absence of stimulation. An interesting finding however was a significant increase in AR expression in asthmatic ASM of both sexes, which likely occurs in females independent of changes in androgen levels. The effects of inflammation per se is suggested by the findings of increased AR expression in both non-asthmatic and asthmatic ASM with cytokine exposure. With inflammation known to enhance contractility [38, 39] , increased AR expression permits continued bronchodilatory effects of TES. What is less clear is the functional significance of such increased AR expression in female airways where TES or other androgens are likely to be still at very low levels.
Our studies show that TES, via AR, reduce [Ca 2+ ] i responses to agonist in both male and female ASM, highligthing functionality of the AR in both sexes. Interestingly, consistent with upregulated AR in both males and females, TES continued to reduce [Ca 2+ ] i even in asthmatic ASM or with TNFα or IL-13 exposure, suggesting maintained functionality that would be of physiological significance at least in males. However, it is also interesting to note that the decrease in [Ca 2+ ] i by TES or DHT was more pronounced in female asthmatics (again consistent with the greater change in AR in this sex). This surprising finding suggests a potentially novel approach to inducing bronchodilation in females by targeting the AR, especially if done by local administration to the airways to minimize systemic androgenic effects in women.
The likely genomic effects of TES following extended exposure appear to target [Ca 2+ ] I regulatory mechanisms that are known to be increased in the context of asthma or cytokine exposure: LTCC, STIM1 and Orai1 [38] [39] [40] 62] . These Ca 2+ influx mechanisms are also involved in mediating TES effects on [Ca 2+ ] i as suggested by the effects of inhibitors such as nifedipine. Earlier studies suggest, TES inhibits LTCC non-genomically [62] . However, limited data in other cell types suggest TES actually increases LTCC [63] . Thus TES effects on this pathway may be cell-type dependent. Furthermore, [Ca 2+ ] i studies performed in zero extracellular calcium especially in the presence of TNFα or IL-13 show significant effects of TES/DHT suggesting a role for sarcoplasmic reticulum Ca 2+ release pathways such as the IP3 or RyR receptors that are known to be important in ASM Ca 2+ regulation [11, 38, 40, 64, 65] . Here, limited evidence does show that TES directly binds to IP3R and modifies its function in ASM [32] .
Exploration of SOCE showed increased influx via this pathway following TNFα and to a lesser extent IL-13 exposure. TNFα and IL-13 have been shown to increase SOCE activity by increasing expression of the regulatory STIM1 protein and the Orai1 channel as well as downregulating TMEM66 in human ASM cells [18, 40, 64] . TNFα induced enhancement of SOCE was blunted by TES as was expression of STIM1 and Orai1 with concordant increase in TMEM66 that is involved in downregulating SOCE.
Conclusion
In conclusion, AR is expressed and is functional in ASM of both males and females, with a surprising greater increase in female ASM in asthmatics or with inflammaotry cytokine exposure. AR remains functional in disease, and its activation leads to decreased [Ca 2+ ] i via both inhibited Ca 2+ influx and reduced intracellular Ca 2+ release. Thus AR activation may be a viable and interesting apporach to inducing bronchodilation in both sexes.
